These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Dantzer R Eur J Pharmacol; 2004 Oct; 500(1-3):399-411. PubMed ID: 15464048 [TBL] [Abstract][Full Text] [Related]
23. Oncology in neuroimmunomodulation. What progress has been made? Conti A Ann N Y Acad Sci; 2000; 917():68-83. PubMed ID: 11268398 [TBL] [Abstract][Full Text] [Related]
26. Natural immunity to cancer in humans. Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124 [TBL] [Abstract][Full Text] [Related]
27. Neuroimmunomodulation and immune privilege: the role of neuropeptides in ocular immunosuppression. Taylor AW Neuroimmunomodulation; 2002-2003; 10(4):189-98. PubMed ID: 12584406 [TBL] [Abstract][Full Text] [Related]
28. Innate immune mediators in cancer: between defense and resistance. Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320 [TBL] [Abstract][Full Text] [Related]
29. Enhancing Cancer Immunotherapy Via Activation of Innate Immunity. Goldberg JL; Sondel PM Semin Oncol; 2015 Aug; 42(4):562-72. PubMed ID: 26320061 [TBL] [Abstract][Full Text] [Related]
30. Neuroimmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response. Ortega E; Giraldo E; Hinchado MD; Martín L; García JJ; De la Fuente M Neuroimmunomodulation; 2007; 14(3-4):206-12. PubMed ID: 18073516 [TBL] [Abstract][Full Text] [Related]
31. Natural immunity has significant impact on immune responses against cancer. Rubin B Scand J Immunol; 2009 Mar; 69(3):275-90. PubMed ID: 19281540 [TBL] [Abstract][Full Text] [Related]
32. Neuro-immune interactions in allergic diseases: novel targets for therapeutics. Voisin T; Bouvier A; Chiu IM Int Immunol; 2017 Jun; 29(6):247-261. PubMed ID: 28814067 [TBL] [Abstract][Full Text] [Related]
33. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment. Wu D Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492 [TBL] [Abstract][Full Text] [Related]
34. NK cell-based cancer immunotherapy: from basic biology to clinical application. Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912 [TBL] [Abstract][Full Text] [Related]
35. A reinterpretation of the pathogenesis and cure of cancer according to the psychoneuroimmunological discoveries. Lissoni P Methods Mol Biol; 2012; 934():183-92. PubMed ID: 22933147 [TBL] [Abstract][Full Text] [Related]
36. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines. Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238 [TBL] [Abstract][Full Text] [Related]
37. Neuroimmune mechanisms in cancer pain. Brown MR; Ramirez JD Curr Opin Support Palliat Care; 2015 Jun; 9(2):103-11. PubMed ID: 25872124 [TBL] [Abstract][Full Text] [Related]
38. Impact of IL-12 in Cancer. Lu X Curr Cancer Drug Targets; 2017; 17(8):682-697. PubMed ID: 28460617 [TBL] [Abstract][Full Text] [Related]
39. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies. Fujii S Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215 [TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Roilides E; Antachopoulos C; Simitsopoulou M Mycoses; 2014 Dec; 57 Suppl 3():40-7. PubMed ID: 25175306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]